The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial
Crossref DOI link: https://doi.org/10.1007/s00330-015-4082-8
Published Online: 2015-11-11
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jamshidi, Neema
Jonasch, Eric
Zapala, Matthew
Korn, Ronald L.
Brooks, James D.
Ljungberg, Borje
Kuo, Michael D.
Text and Data Mining valid from 2015-11-11